BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7656445)

  • 21. Porphyria cutanea tarda and chronic lymphoid leukemia.
    Remenyik E; Ujj G; Kiss A; Kószó F; Horkay I
    Photodermatol Photoimmunol Photomed; 1996 Aug; 12(4):180-2. PubMed ID: 9017795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Porphyria cutanea tarda in three generations of a single family.
    Benedetto AV; Kushner JP; Taylor JS
    N Engl J Med; 1978 Feb; 298(7):358-62. PubMed ID: 622106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Porphyria cutanea tarda: a case report.
    Usta Atmaca H; Akbas F
    J Med Case Rep; 2019 Jan; 13(1):17. PubMed ID: 30661508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defective human erythrocyte uroporphyrinogen decarboxylase in familial porphyria cutanea tarda: the metabolic lesion or the result of endogenous porphyrinemia?
    Mukerji SK; Pimstone NR
    Biochem Biophys Res Commun; 1988 Jul; 154(1):39-46. PubMed ID: 3395340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda?
    Elder GH; Smith SG; Herrero C; Lecha M; Mascaro JM; Muniesa AM; Czarnecki DB; Brenan J; Poulos V; DE Salamanca RE
    Lancet; 1981 Apr; 1(8226):916-9. PubMed ID: 6112327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT).
    Cappellini MD; Martinez di Montemuros F; Tavazzi D; Fargion S; Pizzuti A; Comino A; Cainelli T; Fiorelli G
    Hum Mutat; 2001 Apr; 17(4):350. PubMed ID: 11295834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Porphyria cutanea tarda and chronic renal failure.
    Harlan SL; Winkelmann RK
    Mayo Clin Proc; 1983 Jul; 58(7):467-71. PubMed ID: 6345943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The molecular basis of porphyria cutanea tarda in Chile: identification and functional characterization of mutations in the uroporphyrinogen decarboxylase gene.
    Poblete-Gutiérrez P; Mendez M; Wiederholt T; Merk HF; Fontanellas A; Wolff C; Frank J
    Exp Dermatol; 2004 Jun; 13(6):372-9. PubMed ID: 15186324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies.
    Aarsand AK; Boman H; Sandberg S
    Clin Chem; 2009 Apr; 55(4):795-803. PubMed ID: 19233912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Porphyria cutanea tarda.
    Williams DS
    J Insur Med; 2007; 39(4):293-5. PubMed ID: 18522149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porphyria cutanea tarda.
    Elder GH
    Semin Liver Dis; 1998; 18(1):67-75. PubMed ID: 9516680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Enzymatic and molecular studies in a case of hepato-erythropoietic porphyria. Homozygote form of type familial cutaneous porphyria].
    de Verneuil H; Moreau-Gaudry F; Laradi S; Cruces MJ; de la Torre C; Aris LF
    Arch Fr Pediatr; 1992 Dec; 49(10):907-11. PubMed ID: 1363904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatoerythropoietic porphyria: relationship with familial porphyria cutanea tarda.
    Castaño Suárez E; Zamarro Sanz O; Guerra Tapia A; Enríquez de Salamanca R
    Dermatology; 1996; 193(4):332-5. PubMed ID: 8993961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The first Japanese case of familial porphyria cutanea tarda diagnosed by a UROD mutation.
    Matsui A; Akasaka E; Rokunohe D; Matsuzaki Y; Sawamura D; Nakano H
    J Dermatol Sci; 2019 Jan; 93(1):65-67. PubMed ID: 30522880
    [No Abstract]   [Full Text] [Related]  

  • 35. Incidence of hereditary porphyria cutanea tarda (PCT) in a sample of the Italian population.
    D'Alessandro L; Griso D; Biolcati G; Macrì A; Topi GC
    Arch Dermatol Res; 1992; 284(4):212-4. PubMed ID: 1358034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
    Felsher BF; Carpio NM; Engleking DW; Nunn AT
    N Engl J Med; 1982 Apr; 306(13):766-9. PubMed ID: 7062951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda.
    Elder GH; Sheppard DM; Tovey JA; Urquhart AJ
    Lancet; 1983 Jun; 1(8337):1301-4. PubMed ID: 6134095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial and sporadic porphyria cutanea: two different diseases.
    de Verneuil H; Aitken G; Nordmann Y
    Hum Genet; 1978 Oct; 44(2):145-51. PubMed ID: 730158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
    Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
    J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.
    Franklin MR; Phillips JD; Kushner JP
    Toxicol Appl Pharmacol; 1997 Dec; 147(2):289-99. PubMed ID: 9439724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.